Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty
Public ClinicalTrials.gov record NCT03169231. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Blinded and Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Longeveron Allogenic Human Mesenchymal Stem Cells Infusion in Patients With Aging Frailty
Study identification
- NCT ID
- NCT03169231
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Longeveron Inc.
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- Longeveron Mesenchymal Stem Cells (LMSCs) Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 70 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 5, 2017
- Primary completion
- Sep 29, 2021
- Completion
- Sep 29, 2021
- Last update posted
- Mar 6, 2022
2017 – 2021
United States locations
- U.S. sites
- 7
- U.S. states
- 1
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Soffer Health Institute | Aventura | Florida | 33180 | — |
| Clinical Research of South Florida | Coral Gables | Florida | 33134 | — |
| Clinical Physiology Associates | Fort Myers | Florida | 33912 | — |
| Miami VA Healthcare System | Miami | Florida | 33125 | — |
| Vista Health Research | Miami | Florida | 33176 | — |
| Panax Clinical Research | Miami Lakes | Florida | 33014 | — |
| Advanced Research for Health Improvement, LLC | Naples | Florida | 34102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03169231, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2022 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03169231 live on ClinicalTrials.gov.